Research published in this month’s Archives of General Psychiatry evaluated the use of a monoclonal antibody (mAb) against tumor necrosis factor (TNF) alpha for treatment resistant depression.
Researchers at Emory University studied whether blocking inflammation would be a useful treatment …
How close are we to implementing the idea of personalized medicine in psychiatry? Next year the International Congress on Neuropsychopharmacology (CINP) is holding a thematic meeting in April 2013 entitled “Pharmacogenomics and Personalized Medicine in Psychiatry.” An ‘All …
Research published in the American Journal of Psychiatry demonstrates that elderly patients who are cognitively intact and diagnosed with major depression may have low levels of amyloid beta 42 (Aß-42) in cerebral spinal fluid (CSF).
Aß-42 has been implicated in …
According to a study in the Archives of General Psychiatry, approximately 90% of patients with MCI and pathologic CSF biomarker levels at baseline develop AD within 9 to 10 years. Levels of Aβ42 are already fully decreased at least …
A new research report appearing in the December issue of the FASEB Journal shows how scientists from the United Kingdom have developed a simple blood test to detect Parkinson’s disease even at the earliest stages. The test is possible because …